There were 1,676 press releases posted in the last 24 hours and 413,769 in the last 365 days.

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Exelon Corporation

LOS ANGELES, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 14, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Exelon Corporation (“Exelon” or the “Company”) (NASDAQ: EXC) investors who purchased securities between February 9, 2019 and November 1, 2019, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.

On July 15, 2019, Exelon announced that the Company and Commonwealth Edison (“ComEd”), which is owned by Exelon, had received a grand jury subpoena from the U.S. Attorney concerning Exelon’s lobbying activities in Illinois.

Then, on October 9, 2019, Exelon disclosed receipt of a second grand jury subpoena regarding its communications with Illinois State Senator Martin Sandoval.

On October 15, 2019, Exelon announced the abrupt exit of Anne Pramaggiore, Chief Executive Officer of Exelon Utilities. Analysts immediately identified the criminal subpoenas and Pramaggiore’s abrupt resignation as “being directly related to each other.”

On this news, Exelon’s share price fell $2.15, or nearly 5%, to close at $44.91 per share on October 16, 2019, thereby injuring investors.

Then, on October 31, 2019, the Company revealed that the U.S. Securities and Exchange Commission had also opened an investigation into the Company’s lobbying activities, but declined to state whether the investigations went beyond Illinois.

On this news, Exelon’s share price fell $1.17, or nearly 3%, to close at $45.49 per share on October 31, 2019, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Exelon and/or its employees were engaged in unlawful lobbying activities; (2) that the foregoing increased the risk of a criminal investigation into Exelon; (3) that ComEd's revenues were in part the product of unlawful conduct and thus unsustainable; and (4) that, as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased or otherwise acquired Exelon securities during the Class Period, you may move the Court no later than February 14, 2020 to request appointment as lead plaintiff in this putative class action lawsuit. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.  If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Primary Logo